The Latest Breaking News from Path

UiPath Gets Hit With Downgrade Following Investor Day. Why Analysts Weren’t Impressed.

UiPath’s AI ambitions met cautious investor sentiment, with pricing concerns and competitive pressure prompting a more skeptical analyst outlook.

Barchart · Oct 3

Mamdani's Plan To Fight Antisemitism Will Fuel the NYC Nonprofit Complex

Mamdani wants to spend millions of dollars fighting "hate." Where does the money go?

Reason · Oct 1

These 3 Agentic AI Stocks Have More Than Hype Behind Their Growth Stories

ServiceNow, UiPath, and Palo Alto Networks show real agentic AI traction through earnings growth, enterprise adoption, and partnerships, making their fundamentals worth watching amid market volatility.

MarketBeat · Sep 19

UiPath Fell on Good News—That Could Be the Opportunity

UiPath is well-positioned to accelerate growth through AI adoption as it leans into agentic services. Client wins and retention point to strength in 2026.

MarketBeat · Mar 12

HPV vaccine rollout faces wild theories and real questions. The govt is unready for both

The recent launch of a nationwide vaccination programme aimed at preventing cervical cancer in teenage girls and women has been met with scepticism and doomsday predictions by a section of very vocal critics of vaccination on social media. 

Newslaundry · Mar 5

5 Ways the Potential Friday Night Government Shutdown Will Impact NYC Commuters

Washington gridlock has returned, and the clock is ticking toward a midnight deadline this Friday, January 30. While political standoffs often feel distant, a federal funding lapse creates real ripples in the daily life of New York City. Commuters, travelers, and residents are right to wonder how a shutdown affects…

Budget and the Bees · Jan 29

What is Nipah virus? Symptoms to watch out for as India races to contain deadly outbreak

Nipah is a deadly virus with no vaccine or cure and considered a high-risk pathogen by the World Health Organization

The Independent UK · Jan 23

The Next Market Leaders? 5 Growth Stocks to Watch in 2026

Growth and mid-cap stocks with real earnings power and improving fundamentals tend to outperform when market leadership broadens beyond mega-caps.

MarketBeat · Jan 12

Dear UiPath Stock Fans, Mark Your Calendars for January 2

UiPath stock jumped after news it will join the S&P MidCap 400, a move that could reshape near-term trading dynamics and investor attention.

Barchart · Dec 30, 2025

UiPath Surges on Earnings: Should Investors Chase the Momentum?

UiPath has surged 36% over the prior week after beating Q3 earnings and hitting new 52-week highs, drawing fresh investor attention.

MarketBeat · Dec 9, 2025